(Q37981765)

26 August 2017

title

Immunosenescence and herd immunity: with an ever-increasing aging population do we need to rethink vaccine schedules? (English)

1 reference

26 August 2017

1 reference

Pierre Olivier Lang

1

1 reference

26 August 2017

Richard Aspinall

series ordinal

2

1 reference

26 August 2017

publication date

1 February 2012

1 reference

Expert Review of Vaccines

26 August 2017

published in

1 reference

26 August 2017

volume

11

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

167-176

1 reference

Doubling of world population unlikely

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Demography. Broken limits to life expectancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Aging, frailty and age-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Functional ability in the elderly Swedish population from 1980 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Epidemiology and unique aspects of aging and infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Immunity to and frequency of reinfection with respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Effects of aging on the adaptive immune response to respiratory virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Risk factors for severe respiratory syncytial virus infection in elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Rhinovirus and coronavirus infection-associated hospitalizations among older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Rhinovirus infections in myelosuppressed adult blood and marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Impact of respiratory virus infections on persons with chronic underlying conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Rhinovirus outbreak in a long term care facility for elderly persons associated with unusually high mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Community-acquired bacterial meningitis in elderly patients: experience over 30 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Immunosenescence: Implications for vaccination programmes in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Determining the optimal pneumococcal vaccination strategy for adults: is there a role for the pneumococcal conjugate vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Promoting life course vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Immunity in the elderly: the role of the thymus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Redefining chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Nutritional factors and immunological ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Aging adults and seasonal influenza: does the vitamin d status (h)arm the body?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Protein hormones and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Immunosenescence and vaccine failure in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Immunisation and herd immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Herd immunity and herd effect: new insights and definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

The Japanese experience with vaccinating schoolchildren against influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

[Estimation of excess mortality associated with influenza epidemics specific for sex, age and cause of death in Japan during 1987-2005].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Trends in pertussis among infants in the United States, 1980-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Analysis of Bordetella pertussis populations in European countries with different vaccination policies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Resurgence of pertussis in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Bacterial meningitis in the United States, 1998-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Varicella-zoster vaccine for the prevention of herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Perspective: aging and infectious diseases: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

The Age-Old Struggle against the Antivaccinationists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

The next decade of vaccines: societal and scientific challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

The basis of persistent bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Global trends in emerging infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

The outbreak of West Nile virus infection in the New York City area in 1999

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Outcome of West Nile fever in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Development, feasibility and performance of a health risk appraisal questionnaire for older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Application of pharmacogenomics to vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Reverse vaccinology: developing vaccines in the era of genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Anti-vaccinationists past and present

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

RETRACTED: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Chickenpox party or varicella vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

The continuing tensions between individual rights and public health. Talking Point on public health versus civil liberties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Inactivated influenza vaccines: recent progress and implications for the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Age effects on B cells and humoral immunity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Real time-PCR assay estimating the naive T-cell pool in whole blood and dried blood spot samples: pilot study in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Tracing thymic output in older individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Thymic output: a bad TREC record

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

A global prescription for adult immunization: Time is catching up with us

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of Bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.11.187

21 January 2018

Identifiers

DOI

10.1586/ERV.11.187

1 reference

26 August 2017

1 reference